Hologic, Inc. (HOLX)
USD 58.46
(-4.59%)
USD 58.46
(-4.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 1.34 Billion USD | 2.69% |
| 2023 | 1.31 Billion USD | -4.14% |
| 2022 | 1.36 Billion USD | 4.09% |
| 2021 | 1.31 Billion USD | 19.05% |
| 2020 | 1.1 Billion USD | -6.65% |
| 2019 | 1.18 Billion USD | -0.61% |
| 2018 | 1.18 Billion USD | 4.53% |
| 2017 | 1.13 Billion USD | 13.24% |
| 2016 | 1 Billion USD | 5.81% |
| 2015 | 949.1 Million USD | 4.47% |
| 2014 | 908.5 Million USD | 3.23% |
| 2013 | 880.06 Million USD | 18.0% |
| 2012 | 745.8 Million USD | 39.13% |
| 2011 | 536.05 Million USD | -5.34% |
| 2010 | 566.28 Million USD | 6.18% |
| 2009 | 533.34 Million USD | 2.87% |
| 2008 | 518.47 Million USD | 162.1% |
| 2007 | 197.81 Million USD | 60.44% |
| 2006 | 123.29 Million USD | 53.36% |
| 2005 | 80.39 Million USD | 10.46% |
| 2004 | 72.78 Million USD | 3.16% |
| 2003 | 70.55 Million USD | 4.39% |
| 2002 | 67.58 Million USD | -15.09% |
| 2001 | 79.6 Million USD | 28.55% |
| 2000 | 61.92 Million USD | 32.03% |
| 1999 | 46.9 Million USD | -7.68% |
| 1998 | 50.8 Million USD | 33.33% |
| 1997 | 38.1 Million USD | 6.72% |
| 1996 | 35.7 Million USD | 107.56% |
| 1995 | 17.2 Million USD | 21.99% |
| 1994 | 14.1 Million USD | 4.44% |
| 1993 | 13.5 Million USD | 15.38% |
| 1992 | 11.7 Million USD | 34.48% |
| 1991 | 8.7 Million USD | 17.57% |
| 1990 | 7.4 Million USD | 32.14% |
| 1989 | 5.6 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 327.6 Million USD | 7.62% |
| 2024 Q2 | 319.2 Million USD | -6.34% |
| 2024 Q3 | 304.4 Million USD | -4.64% |
| 2024 Q1 | 340.8 Million USD | 9.41% |
| 2023 Q2 | 324.3 Million USD | -8.49% |
| 2023 Q4 | 311.5 Million USD | -2.56% |
| 2023 Q3 | 319.7 Million USD | -1.42% |
| 2023 FY | 1.31 Billion USD | -4.14% |
| 2023 Q1 | 354.4 Million USD | 2.87% |
| 2022 Q4 | 344.5 Million USD | 7.49% |
| 2022 Q3 | 320.5 Million USD | -9.13% |
| 2022 Q1 | 348.9 Million USD | -8.78% |
| 2022 FY | 1.36 Billion USD | 4.09% |
| 2022 Q2 | 352.7 Million USD | 1.09% |
| 2021 FY | 1.31 Billion USD | 19.05% |
| 2021 Q1 | 288.9 Million USD | 0.14% |
| 2021 Q2 | 302.1 Million USD | 4.57% |
| 2021 Q3 | 339.4 Million USD | 12.35% |
| 2021 Q4 | 382.5 Million USD | 12.7% |
| 2020 Q4 | 288.5 Million USD | 5.25% |
| 2020 Q3 | 274.1 Million USD | 15.9% |
| 2020 Q2 | 236.5 Million USD | -22.13% |
| 2020 FY | 1.1 Billion USD | -6.65% |
| 2020 Q1 | 303.7 Million USD | 1.98% |
| 2019 FY | 1.18 Billion USD | -0.61% |
| 2019 Q1 | 291.9 Million USD | -8.52% |
| 2019 Q2 | 294.8 Million USD | 0.99% |
| 2019 Q3 | 296.8 Million USD | 0.68% |
| 2019 Q4 | 297.8 Million USD | 0.34% |
| 2018 Q3 | 297.1 Million USD | 3.95% |
| 2018 Q2 | 285.8 Million USD | -0.28% |
| 2018 Q1 | 286.6 Million USD | -6.34% |
| 2018 FY | 1.18 Billion USD | 4.53% |
| 2018 Q4 | 319.1 Million USD | 7.4% |
| 2017 Q2 | 287 Million USD | 12.28% |
| 2017 Q3 | 288.6 Million USD | 0.56% |
| 2017 Q4 | 306 Million USD | 6.03% |
| 2017 Q1 | 255.6 Million USD | -0.2% |
| 2017 FY | 1.13 Billion USD | 13.24% |
| 2016 Q4 | 256.1 Million USD | 1.55% |
| 2016 Q1 | 250.7 Million USD | 1.42% |
| 2016 FY | 1 Billion USD | 5.81% |
| 2016 Q3 | 252.2 Million USD | 2.9% |
| 2016 Q2 | 245.1 Million USD | -2.23% |
| 2015 Q3 | 250.8 Million USD | 11.86% |
| 2015 Q2 | 224.2 Million USD | -1.28% |
| 2015 Q1 | 227.1 Million USD | -2.49% |
| 2015 FY | 949.1 Million USD | 4.47% |
| 2015 Q4 | 247.2 Million USD | -1.44% |
| 2014 Q3 | 229.9 Million USD | 4.6% |
| 2014 Q4 | 232.9 Million USD | 1.3% |
| 2014 FY | 908.5 Million USD | 3.23% |
| 2014 Q1 | 225.96 Million USD | 12.86% |
| 2014 Q2 | 219.78 Million USD | -2.73% |
| 2013 FY | 880.06 Million USD | 18.0% |
| 2013 Q4 | 200.21 Million USD | -8.93% |
| 2013 Q3 | 219.84 Million USD | -4.89% |
| 2013 Q2 | 231.13 Million USD | 0.99% |
| 2013 Q1 | 228.86 Million USD | -8.67% |
| 2012 FY | 745.8 Million USD | 39.13% |
| 2012 Q1 | 167.04 Million USD | -1.79% |
| 2012 Q3 | 161.88 Million USD | -3.11% |
| 2012 Q4 | 250.6 Million USD | 54.8% |
| 2012 Q2 | 167.09 Million USD | 0.03% |
| 2011 Q3 | 157.62 Million USD | 142.42% |
| 2011 Q1 | 152.51 Million USD | 9.21% |
| 2011 Q2 | 65.02 Million USD | -57.37% |
| 2011 FY | 536.05 Million USD | -5.34% |
| 2011 Q4 | 170.08 Million USD | 7.91% |
| 2010 Q2 | 151.52 Million USD | 5.24% |
| 2010 FY | 566.28 Million USD | 6.18% |
| 2010 Q3 | 131.11 Million USD | -13.47% |
| 2010 Q4 | 139.64 Million USD | 6.51% |
| 2010 Q1 | 143.98 Million USD | 10.51% |
| 2009 Q2 | 135.09 Million USD | -1.35% |
| 2009 Q1 | 136.94 Million USD | 2.52% |
| 2009 Q3 | 132.39 Million USD | -1.99% |
| 2009 Q4 | 130.3 Million USD | -1.59% |
| 2009 FY | 533.34 Million USD | 2.87% |
| 2008 Q2 | 133.52 Million USD | 10.7% |
| 2008 Q4 | 133.57 Million USD | 2.15% |
| 2008 Q3 | 130.75 Million USD | -2.07% |
| 2008 Q1 | 120.61 Million USD | 136.27% |
| 2008 FY | 518.47 Million USD | 162.1% |
| 2007 FY | 197.81 Million USD | 60.44% |
| 2007 Q1 | 47.83 Million USD | 34.45% |
| 2007 Q2 | 48.74 Million USD | 1.89% |
| 2007 Q3 | 50.18 Million USD | 2.95% |
| 2007 Q4 | 51.05 Million USD | 1.73% |
| 2006 Q1 | 24.97 Million USD | 21.57% |
| 2006 Q4 | 35.58 Million USD | 11.86% |
| 2006 Q3 | 31.8 Million USD | 19.01% |
| 2006 Q2 | 26.72 Million USD | 7.02% |
| 2006 FY | 123.29 Million USD | 53.36% |
| 2005 Q2 | 19.59 Million USD | -0.13% |
| 2005 Q3 | 20.63 Million USD | 5.34% |
| 2005 Q4 | 20.54 Million USD | -0.46% |
| 2005 FY | 80.39 Million USD | 10.46% |
| 2005 Q1 | 19.61 Million USD | 9.49% |
| 2004 Q3 | 18.75 Million USD | 5.71% |
| 2004 Q2 | 17.74 Million USD | -3.35% |
| 2004 Q4 | 17.91 Million USD | -4.49% |
| 2004 Q1 | 18.36 Million USD | 12.76% |
| 2004 FY | 72.78 Million USD | 3.16% |
| 2003 FY | 70.55 Million USD | 4.39% |
| 2003 Q4 | 16.28 Million USD | -6.67% |
| 2003 Q2 | 18 Million USD | -4.31% |
| 2003 Q3 | 17.44 Million USD | -3.12% |
| 2003 Q1 | 18.81 Million USD | 12.59% |
| 2002 Q4 | 16.71 Million USD | -2.33% |
| 2002 Q2 | 16.89 Million USD | 0.09% |
| 2002 Q1 | 16.87 Million USD | -12.89% |
| 2002 FY | 67.58 Million USD | -15.09% |
| 2002 Q3 | 17.11 Million USD | 1.31% |
| 2001 Q3 | 18.4 Million USD | -14.78% |
| 2001 Q4 | 19.37 Million USD | 5.25% |
| 2001 FY | 79.6 Million USD | 28.55% |
| 2001 Q2 | 21.59 Million USD | -4.12% |
| 2001 Q1 | 22.52 Million USD | 24.93% |
| 2000 Q1 | 14.3 Million USD | 4.38% |
| 2000 FY | 61.92 Million USD | 32.03% |
| 2000 Q2 | 14.89 Million USD | 4.15% |
| 2000 Q3 | 14.3 Million USD | -3.94% |
| 2000 Q4 | 18.03 Million USD | 26.02% |
| 1999 Q2 | 11 Million USD | 5.77% |
| 1999 FY | 46.9 Million USD | -7.68% |
| 1999 Q1 | 10.4 Million USD | -14.75% |
| 1999 Q4 | 13.7 Million USD | 15.13% |
| 1999 Q3 | 11.9 Million USD | 8.18% |
| 1998 FY | 50.8 Million USD | 33.33% |
| 1998 Q2 | 13 Million USD | 11.11% |
| 1998 Q3 | 13.7 Million USD | 5.38% |
| 1998 Q4 | 12.2 Million USD | -10.95% |
| 1998 Q1 | 11.7 Million USD | 23.16% |
| 1997 Q2 | 9.8 Million USD | 3.16% |
| 1997 Q4 | 9.5 Million USD | 3.26% |
| 1997 Q3 | 9.2 Million USD | -6.12% |
| 1997 FY | 38.1 Million USD | 6.72% |
| 1997 Q1 | 9.5 Million USD | -39.87% |
| 1996 Q2 | 6.7 Million USD | 19.64% |
| 1996 Q4 | 15.8 Million USD | 110.67% |
| 1996 Q3 | 7.5 Million USD | 11.94% |
| 1996 Q1 | 5.6 Million USD | 14.29% |
| 1996 FY | 35.7 Million USD | 107.56% |
| 1995 Q2 | 4.2 Million USD | 5.0% |
| 1995 Q3 | 4.4 Million USD | 4.76% |
| 1995 Q1 | 4 Million USD | 2.56% |
| 1995 Q4 | 4.9 Million USD | 11.36% |
| 1995 FY | 17.2 Million USD | 21.99% |
| 1994 Q2 | 3.3 Million USD | 6.45% |
| 1994 Q1 | 3.1 Million USD | -20.51% |
| 1994 FY | 14.1 Million USD | 4.44% |
| 1994 Q4 | 3.9 Million USD | 8.33% |
| 1994 Q3 | 3.6 Million USD | 9.09% |
| 1993 Q2 | 3.1 Million USD | 0.0% |
| 1993 FY | 13.5 Million USD | 15.38% |
| 1993 Q4 | 3.9 Million USD | 18.18% |
| 1993 Q1 | - USD | -100.0% |
| 1993 Q3 | 3.3 Million USD | 6.45% |
| 1992 FY | 11.7 Million USD | 34.48% |
| 1992 Q4 | 3.6 Million USD | 20.0% |
| 1992 Q1 | 2.5 Million USD | 114.79% |
| 1992 Q2 | 2.7 Million USD | 8.0% |
| 1992 Q3 | 3 Million USD | 11.11% |
| 1991 Q1 | - USD | 100.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | -16.9 Million USD | 0.0% |
| 1991 FY | 8.7 Million USD | 17.57% |
| 1990 FY | 7.4 Million USD | 32.14% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q4 | -16.6 Million USD | 0.0% |
| 1990 Q3 | - USD | -100.0% |
| 1990 Q2 | 1.5 Million USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | -9.7 Million USD | 0.0% |
| 1989 FY | 5.6 Million USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -1190.112% |
| AngioDynamics, Inc. | 252.41 Million USD | -432.93% |
| AtriCure, Inc. | 327.05 Million USD | -311.309% |
| Avinger, Inc. | 18.63 Million USD | -7117.513% |
| Azenta, Inc. | 336.26 Million USD | -300.04% |
| BioLife Solutions, Inc. | 117.57 Million USD | -1044.101% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 26.282% |
| Daxor Corporation | 1.28 Million USD | -104951.483% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -5460.746% |
| Femasys Inc. | 15.2 Million USD | -8749.816% |
| GlucoTrack, Inc. | 7.1 Million USD | -18835.811% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -2196.308% |
| ICU Medical, Inc. | 717.04 Million USD | -87.603% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 54.595% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -5052.469% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -1389.091% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1127403.505% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1127403.505% |
| Masimo Corporation | 867 Million USD | -55.156% |
| Microbot Medical Inc. | 9.85 Million USD | -13549.924% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -7202.906% |
| Merit Medical Systems, Inc. | 459.92 Million USD | -192.481% |
| Nephros, Inc. | 9.78 Million USD | -13648.978% |
| NovoCure Limited | 613.92 Million USD | -119.114% |
| NEXGEL, Inc. | 4.09 Million USD | -32741.797% |
| NEXGEL, Inc. | 4.09 Million USD | -32741.797% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -1215.689% |
| OraSure Technologies, Inc. | 125.34 Million USD | -973.224% |
| Pro-Dex, Inc. | 7.37 Million USD | -18132.583% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -2987.162% |
| Predictive Oncology Inc. | 15.22 Million USD | -8732.84% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -15684.823% |
| QuidelOrtho Corporation | 1.35 Billion USD | 0.745% |
| Repligen Corporation | 261.12 Million USD | -415.16% |
| Sanara MedTech Inc. | 61.12 Million USD | -2100.658% |
| STAAR Surgical Company | 224.55 Million USD | -499.054% |
| Sharps Technology, Inc. | 10.12 Million USD | -13183.761% |
| Utah Medical Products, Inc. | 13.26 Million USD | -10044.031% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 25.017% |
| Jin Medical International Ltd. | 3.91 Million USD | -34237.595% |